Bile acid sequestrant SAR-442357 improves experimental type 2 diabetes and comorbidities April 7, 2021
FDA approves Roszet to treat elevated LDL-C in primary nonfamilial hyperlipidemia and HoFH April 1, 2021
ChromaDex announces research initiative to study effects of Niagen and citrin deficiency March 31, 2021
European Commission approves Ontozry for drug-resistant focal-onset seizures in adults March 31, 2021
Yhhu-2407, novel low systemic DGAT1 inhibitor with potential for the treatment of dyslipidemia March 31, 2021
RSS